Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong financial position offer ...
The uptake of GLP-1 has surged since 2022, mainly in US. Read our takeaways from the UBS Evidence Lab survey on key trends in GLP-1 consumer behaviour GLP-1s, also known as glucagon-like peptide 1, ...
Glucagon-like peptide-1 (GLP-1) receptor agonists, such as Wegovy and Ozempic, have taken the food industry by storm. With the potential to significantly change consumer eating habits, they are ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results